COHANCE LIFESCIENCES
Back to Balance Sheet
|
COHANCE LIFESCIENCES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,150 Cr | ₹1,053 Cr | ₹1,136 Cr | ₹852 Cr | ₹918 Cr |
What is the latest Net Current Assets ratio of COHANCE LIFESCIENCES ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹1,150 Cr |
| Mar2025 | ₹1,053 Cr |
| Mar2024 | ₹1,136 Cr |
| Mar2023 | ₹852 Cr |
| Mar2022 | ₹918 Cr |
How is Net Current Assets of COHANCE LIFESCIENCES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,150 Cr | 9.27 | |
| Mar2025 | ₹1,053 Cr | -7.31 | |
| Mar2024 | ₹1,136 Cr | 33.27 | |
| Mar2023 | ₹852 Cr | -7.12 | |
| Mar2022 | ₹918 Cr | - | |
Compare Net Current Assets of peers of COHANCE LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| COHANCE LIFESCIENCES | ₹17,750.7 Cr | 4.4% | 7.1% | -49.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.1% | -5% | 5.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,762.0 Cr | -1.7% | 0.2% | 39.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,448.0 Cr | -2.5% | -5.5% | 30.2% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | 0.9% | -2.6% | -14.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,820.0 Cr | 0.1% | 7.6% | -3.5% | Stock Analytics | |
COHANCE LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| COHANCE LIFESCIENCES | 4.4% |
7.1% |
-49.3% |
| SENSEX | 3.1% |
1% |
-9.1% |
You may also like the below Video Courses